Last updated: 15 December 2023 at 6:40pm EST

David Epstein Net Worth




The estimated Net Worth of David R Epstein is at least 5.99 百万$ dollars as of 10 November 2023. Mr. Epstein owns over 10,620 units of Axcella Health Inc stock worth over 625,619$ and over the last 2024 years he sold AXLA stock worth over 4,130,063$. In addition, he makes 1,232,520$ as Chairman of the Board at Axcella Health Inc.

Mr. Epstein AXLA stock SEC Form 4 insiders trading

David has made over 43 trades of the Axcella Health Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently he sold 10,620 units of AXLA stock worth 2,262,166$ on 10 November 2023.

The largest trade he's ever made was selling 98,737 units of Axcella Health Inc stock on 8 February 2021 worth over 1,469,207$. On average, David trades about 5,804 units every 20 days since 1. As of 10 November 2023 he still owns at least 136,598 units of Axcella Health Inc stock.

You can see the complete history of Mr. Epstein stock trades at the bottom of the page.





David Epstein biography

David Epstein serves as Chairman of the Board of the Company. Mr. Epstein has also served as Executive Partner at Flagship Pioneering Inc., a biotechnology venture creation firm, since January 2017. From January 2010 to July 2016, Mr. Epstein served as Chief Executive Officer of Novartis Pharmaceuticals Corporation, a pharmaceutical company. He currently serves on the boards of directors of International Flavors and Fragrances, Inc. (NYSE: IFF), Evelo Biosciences, Inc. (Nasdaq: EVLO) and of Rubius Therapeutics, Inc. (Nasdaq: RUBY), as Executive Chairman. Mr. Epstein holds an M.B.A. in finance and marketing from Columbia Business School and a B.S. in pharmacy from Rutgers University. Epstein's extensive experience serving in executive roles in the life sciences industry and leading the development and commercialization of numerous therapeutics qualify him to serve on our board of directors

What is the salary of David Epstein?

As the Chairman of the Board of Axcella Health Inc, the total compensation of David Epstein at Axcella Health Inc is 1,232,520$. There are 3 executives at Axcella Health Inc getting paid more, with Shreeram Aradhye having the highest compensation of 3,911,720$.



How old is David Epstein?

David Epstein is 58, he's been the Chairman of the Board of Axcella Health Inc since 2020. There are 2 older and 14 younger executives at Axcella Health Inc. The oldest executive at Axcella Health Inc is Catherine Sohn, 67, who is the Independent Director.

Insiders trading at Axcella Health Inc

Over the last 6 years, insiders at Axcella Health Inc have traded over 32,393$ worth of Axcella Health Inc stock and bought 29,966,648 units worth 79,278,835$ . The most active insiders traders include Ventures Fund Iv General Pa...Ventures Fund Iv General Pa...Des Produits Nestle S.A.Nes.... On average, Axcella Health Inc executives and independent directors trade stock every 31 days with the average trade being worth of 3,073,698$. The most recent stock trade was executed by Margaret Koziel on 1 March 2023, trading 679 units of AXLA stock currently worth 394$.



What does Axcella Health Inc do?

axcella has pioneered a new therapeutic class – defined amino acid compositions (daacs™). our daac therapeutics leverage the essential signaling function of amino acids to restore health across a network of dysregulated pathways, and provide safer solutions for patients with complex disease. with our axcellerator™ platform, we are transforming traditional drug discovery and development by generating patient data in less than a year from indication selection. this platform has delivered a rich pipeline including clinical programs in liver, metabolic, cns and orphan diseases.



Complete history of Mr. Epstein stock trades at Seagen Inc、International Flavors & Fragrances、Evelo Biosciences Inc、Rubius Therapeutics Inc、Axcella Health Inc

インサイダー
取引
取引
合計金額
David R Epstein
CEO
販売 2,262,166$
10 Nov 2023
David R Epstein
ディレクター
オプション行使 10,396$
30 Jun 2022
David R Epstein
ディレクター
オプション行使 10,343$
31 May 2022
David R Epstein
ディレクター
購入する 25,000$
27 May 2022
David R Epstein
ディレクター
オプション行使 12,069$
2 May 2022
David R Epstein
ディレクター
オプション行使 16,699$
31 Mar 2022
David R Epstein
ディレクター
オプション行使 15,394$
28 Feb 2022
David R Epstein
ディレクター
オプション行使 23,197$
31 Jan 2022
David R Epstein
ディレクター
オプション行使 29,901$
31 Dec 2021
David R Epstein
ディレクター
オプション行使 42,462$
30 Nov 2021
David R Epstein
ディレクター
オプション行使 46,640$
1 Nov 2021
David R Epstein
ディレクター
オプション行使 37,790$
1 Oct 2021
David R Epstein
ディレクター
オプション行使 89,832$
3 Sep 2021
David R Epstein
ディレクター
購入する 51,282$
11 Dec 2020
David R Epstein
ディレクター
購入する 44,400$
28 Aug 2020
David R Epstein
ディレクター
購入する 43,200$
21 Apr 2022
David R Epstein
ディレクター
販売 398,691$
11 Feb 2021
David R Epstein
ディレクター
販売 1,469,207$
8 Feb 2021
David R Epstein
ディレクター
購入する 18,800$
17 Mar 2020
David R Epstein
ディレクター
購入する 39,100$
13 Mar 2020
David R Epstein
ディレクター
オプション行使 3,853$
17 Mar 2022
David R Epstein
ディレクター
購入する 50,000$
16 Mar 2022
David R Epstein
ディレクター
オプション行使 2,608$
18 Feb 2022
David R Epstein
ディレクター
オプション行使 2,901$
18 Jan 2022
David R Epstein
ディレクター
オプション行使 3,868$
17 Dec 2021
David R Epstein
ディレクター
オプション行使 4,541$
18 Nov 2021
David R Epstein
ディレクター
オプション行使 4,267$
18 Oct 2021
David R Epstein
ディレクター
オプション行使 4,958$
17 Sep 2021
David R Epstein
ディレクター
オプション行使 4,679$
18 Aug 2021
David R Epstein
ディレクター
オプション行使 5,388$
16 Jul 2021
David R Epstein
ディレクター
オプション行使 6,601$
18 Jun 2021
David R Epstein
ディレクター
オプション行使 5,062$
18 May 2021
David R Epstein
ディレクター
オプション行使 6,524$
18 Apr 2021
David R Epstein
ディレクター
購入する 237,500$
18 May 2020
David R Epstein
ディレクター
購入する 54,186$
27 Feb 2020
David R Epstein
ディレクター
購入する 53,568$
26 Nov 2019
David R Epstein
ディレクター
購入する 53,568$
26 Nov 2019
David R Epstein
ディレクター
購入する 48,587$
1 Aug 2019
David R Epstein
ディレクター
購入する 7,550$
17 Jul 2019
David R Epstein
ディレクター
購入する 47,759$
8 Jul 2019
David R Epstein
ディレクター
購入する 39,911$
1 Jul 2019
David R Epstein
ディレクター
購入する 55,110$
27 Jun 2019
David R Epstein
ディレクター
購入する 138,765$
26 Jun 2019


Axcella Health Inc executives and stock owners

Axcella Health Inc executives and other stock owners filed with the SEC include: